Moxifloxacin Acino (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacin Acino, is a fluoroquinolone antibiotic presented as a solution for injection for intravenous use. It treats a range of serious bacterial infections in adult patients.

GNH USA supplies Moxifloxacin Acino as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in the respiratory, skin and intra‑abdominal systems. - Community‑acquired pneumonia: effective treatment of infection caused by susceptible bacteria. - Acute bacterial sinusitis: eradicates the causative pathogens and relieves sinus inflammation. - Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves airflow. - Complicated skin and skin‑structure infections: targets Gram‑positive and Gram‑negative organisms. - Complicated intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic flora.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: mild to moderate intensity. - Dizziness: occasional vertigo or light‑headedness. - Rash: mild skin erythema or pruritus. - Transient elevation of liver enzymes: mild, reversible increase in ALT/AST.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles, may occur during or after therapy. - QT interval prolongation: risk of ventricular arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile‑associated diarrhea: potentially life‑threatening colitis. - Hepatic failure: rare but serious liver injury. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin reactions.

Before initiating therapy, consider patient‑specific factors and monitor for adverse events. - Pregnancy: Category C – use only if potential benefits justify the risk to the fetus. - Renal impairment: dose adjustment may be required in patients with reduced clearance. - History of tendon disorders: avoid use due to risk of tendon rupture. - Concurrent QT‑prolonging drugs: monitor ECG and electrolytes closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Moxifloxacin can interact with several drug classes; awareness helps prevent toxicity.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: increased risk of cumulative toxicity. - Concurrent use of drugs that prolong the QT interval (e.g., macrolides, antiarrhythmics): heightened arrhythmia risk. - Antacids containing aluminum or magnesium: markedly reduce moxifloxacin absorption.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase central nervous system side effects. - Warfarin: potential enhancement of anticoagulant effect; monitor INR regularly.